1. Home
  2. ZWS vs CYTK Comparison

ZWS vs CYTK Comparison

Compare ZWS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

N/A

Current Price

$47.26

Market Cap

7.9B

Sector

Industrials

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$63.90

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZWS
CYTK
Founded
1892
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.6B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
ZWS
CYTK
Price
$47.26
$63.90
Analyst Decision
Buy
Strong Buy
Analyst Count
6
18
Target Price
$49.33
$87.56
AVG Volume (30 Days)
774.6K
1.7M
Earning Date
05-05-2026
05-25-2026
Dividend Yield
0.93%
N/A
EPS Growth
25.00
N/A
EPS
1.15
N/A
Revenue
$1,530,500,000.00
$13,368,000.00
Revenue This Year
$6.90
$9.79
Revenue Next Year
$5.13
$302.66
P/E Ratio
$41.12
N/A
Revenue Growth
19.40
N/A
52 Week Low
$27.74
$29.31
52 Week High
$53.17
$70.98

Technical Indicators

Market Signals
Indicator
ZWS
CYTK
Relative Strength Index (RSI) 34.23 50.66
Support Level $45.14 $59.25
Resistance Level $48.40 $65.93
Average True Range (ATR) 1.25 2.54
MACD -0.57 -0.34
Stochastic Oscillator 27.37 41.35

Price Performance

Historical Comparison
ZWS
CYTK

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: